The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
“Nuclear receptors (NRs) are transcription factors that are typically regulated by the binding of specific ligands, such as glucocorticoids, oestrogen, thyroid hormone and retinoic aci”
BackgroundGene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Rosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Overview of nomenclature of nuclear receptors
Germain, P., Staels, B., Dacquet, C., Spedding, M., & Laudet, V. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.2 · Cited by 688
“Indeed, the agonist-bound GR physically interacts with NF-(cid:2) B to block its transcriptional activity (McKay and Cidlowski, 1999; De Bosscher et al., 2003).”
BackgroundMolecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
“…of signal-dependent gene expression, demonstrating that GR, PPARγ, and LXR repress overlapping but distinct subsets of inflammatory response genes, consistent with the large number of mechanisms that have been proposed for negative regulation by nuclear receptors (De Bosscher et al., 2003).”
BackgroundInfluentialNuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure
van Bodegom, M., Homberg, J. R., & Henckens, M. J. A. G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00087 · Cited by 562
Glucocorticoid receptor control of transcription: precision and plasticity via allostery
Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.152 · Cited by 533
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
“glucocorticoids are effected, at least in part, through repression of NF-kB transactivation (reviewed in De Bosscher et al.(52)).”
BackgroundAn inflammatory review of glucocorticoid actions in the CNS
Sorrells, S. F., & Sapolsky, R. M. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.006 · Cited by 458
Combinatorial roles of nuclear receptors in inflammation and immunity
Glass, C. K., & Ogawa, S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1748 · Cited by 464
IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation
Puccetti, P., & Grohmann, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2163 · Cited by 453
Inflammation and post‐traumatic stress disorder
Hori, H., & Kim, Y. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12820 · Cited by 407
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.048 · Cited by 417
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425
Mechanisms of glucocorticoid receptor signaling during inflammation
Smoak, K. A., & Cidlowski, J. A. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.06.010 · Cited by 420
Corticosteroid effects in the brain: U-shape it
Joëls, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.03.007 · Cited by 411
Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I. M., & De Bosscher, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.014 · Cited by 411
Zhou, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26283 · Cited by 402
Transcription factor cross-talk: the estrogen receptor and NF-κB
Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
ZHOU, J., & CIDLOWSKI, J. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.006 · Cited by 372
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T., Punaro, M., Bolland, S., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380
Immune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
The pathogenesis of systemic lupus erythematosus—an update
Choi, J., Kim, S. T., & Craft, J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.10.004 · Cited by 360
Lichtenstein, G. R., Sbreu, M. T., Cohen, R. D., & Tremaine, W. J. (2006) · PubMed · Cited by 380
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357
Mechanisms of Mineralocorticoid Action
Fuller, P. J., & Young, M. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000193502.77417.17 · Cited by 329
Newton, R., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 328
“1A) (De Bosscher et al., 2003).”
BackgroundAn Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
Talley, N. J., Abreu, M. T., Achkar, J.-P., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., Kane, S. V., Sandborn, W. J., Ullman, T. A., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.58 · Cited by 310
“Corticosteroids also induce apoptosis of activated lymphocytes and decrease inflammatory cytokine expression (”
BackgroundGlucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Frank, M. G., Thompson, B. M., Watkins, L. R., & Maier, S. F. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.005 · Cited by 310
“It is problematic that GCs, which are universally considered anti-inflammatory and immunosuppressive (Boumpas et al., 1993; De Bosscher et al., 2003), would be elevated during a fight/flight emergency, when the chances of injury and infection increase.”
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Frank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Self-citationde Kloet, E. R., Meijer, O. C., de Nicola, A. F., de Rijk, R. H., & Joëls, M. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.003 · Cited by 278
“In immune disease, this concept has been pursued extensively, inspired by the hope to separate anti-inflammatory actions from other effects by separating classical ‘transrepression’ from ‘transactivation’ (De Bosscher et al., 2003).”
Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
De Bosscher, K., & Haegeman, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0283 · Cited by 284
Self-citationRepeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal
Weber, M. D., Godbout, J. P., & Sheridan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.102 · Cited by 283
“................................................................................................................................................... Neuropsychopharmacology REVIEWS inflammatory signaling molecules (Haegeman et al, 2003).”
Hypothalamic–pituitary–adrenal axis and stress
(2020) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64123-6.00004-7 · Cited by 279
Beyond IκBs: alternative regulation of NF‐KB activity
Neumann, M., & Naumann, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7615rev · Cited by 267
Flaster, H., Bernhagen, J., Calandra, T., & Bucala, R. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0065 · Cited by 260
Mechanisms of Action of Topical Corticosteroids in Psoriasis
Uva, L., Miguel, D., Pinheiro, C., Antunes, J., Cruz, D., Ferreira, J., & Filipe, P. (2012) · International Journal of Endocrinology · doi:10.1155/2012/561018 · Cited by 241
“…acid (broad combination is possible; care must be taken regarding steroid side effects), USA guidelines [6] suggest the use of topical steroids as monotherapy in mild-to-moderate psoriasis or in combination with other topical agents, UV light or systemic agents in moderate-to-severe disease [7].”
BackgroundZhou, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27793 · Cited by 256
A fully dissociated compound of plant origin for inflammatory gene repression
De Bosscher, K., Berghe, W. V., Beck, I. M. E., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., & Haegeman, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505554102 · Cited by 260
Self-citationInteractions of NF-κB with chromatin: the art of being at the right place at the right time
Natoli, G., Saccani, S., Bosisio, D., & Marazzi, I. (2005) · Nature Immunology · doi:10.1038/ni1196 · Cited by 250
Cross-talk between nuclear receptors and nuclear factor κB
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209935 · Cited by 247
“Other NRs have also been shown to upregulate IkBa protein levels; these NRs include PR, AR, PPAR (reviewed in De Bosscher et al., 2003b) and retinoid-related orphan receptor alpha 1 (Delerive et al., 2001).”
BackgroundInfluentialSelf-citationGlucocorticoid Receptor-Dependent Gene Regulatory Networks
Phuc Le, P., Friedman, J. R., Schug, J., Brestelli, J. E., Parker, J. B., Bochkis, I. M., & Kaestner, K. H. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010016 · Cited by 250
“It has been suggested that the activated GR modulates inflammation and the immune response by physically interacting with NF-jB and AP-1, thereby repressing the activation of many of their targets [5,7].”
BackgroundAfricander, D., Verhoog, N., & Hapgood, J. P. (2011) · Steroids · doi:10.1016/j.steroids.2011.03.001 · Cited by 241
Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K., & Muglia, L. J. (2007) · Blood · doi:10.1182/blood-2006-10-048215 · Cited by 249
Bilodeau, S., Vallette-Kasic, S., Gauthier, Y., Figarella-Branger, D., Brue, T., Berthelet, F., Lacroix, A., Batista, D., Stratakis, C., Hanson, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1444606 · Cited by 242
“It is, however, noteworthy that HDAC inhibitors appear to have beneficial effects on progression of different tumors (Drummond et al. 2005).”
BackgroundHippocampal gene expression changes underlying stress sensitization and recovery
Gray, J. D., Rubin, T. G., Hunter, R. G., & McEwen, B. S. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.175 · Cited by 242
“Quantitative RT-PCR validated changes from the microarrays in known stress-induced genes and confirmed alterations in the NfKb pathway genes, Ikbα, RelA and Nfkb1.”
BackgroundInfluentialEpithelial cells and airway diseases
Proud, D., & Leigh, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01033.x · Cited by 229
“Nonetheless, the transrepression model holds that key proinflammatory transcription factors, such as NF-jB and activator protein-1 (AP-1) are inhibited via direct interactions with ligand-bound GR (163).”
BackgroundPost-Translational Modifications of Nuclear Receptors and Human Disease
Anbalagan, M., Huderson, B., Murphy, L., & Rowan, B. G. (2012) · Nuclear Receptor Signaling · doi:10.1621/nrs.10001 · Cited by 211
“GR also reduces inflammatory gene expression induced by NF-κB (Nuclear Factor-κB), AP-1 (Activator Protein-1) or via trans-repression through direct protein interaction with these proteins (reviewed in [De Bosscher et al., 2003]).”
Nuclear receptors versus inflammation: mechanisms of transrepression
Pascual, G., & Glass, C. K. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.005 · Cited by 228
Valledor, A. F., Hsu, L.-C., Ogawa, S., Sawka-Verhelle, D., Karin, M., & Glass, C. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407749101 · Cited by 222
Evolution of the corticosteroid receptor signalling pathway in fish
Bury, N. R., & Sturm, A. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.03.009 · Cited by 222
Recognition of nucleic acids by pattern‐recognition receptors and its relevance in autoimmunity
Kawasaki, T., Kawai, T., & Akira, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01048.x · Cited by 217
“Glucocorticoids have strong anti-inflammatory effects by inhibiting NF-jB activity (128) , but it is not clear why SLE patients commonly need higher doses of glucocorticoids than patients with other autoimmune disease.”
BackgroundCoactivation of GR and NFKB alters the repertoire of their binding sites and target genes
Rao, N. A. S., McCalman, M. T., Moulos, P., Francoijs, K.-J., Chatziioannou, A., Kolisis, F. N., Alexis, M. N., Mitsiou, D. J., & Stunnenberg, H. G. (2011) · Genome Research · doi:10.1101/gr.118042.110 · Cited by 216
“The in- hibitory effect of GR is postulated to be largely due to recruitment of GR, via protein–protein interaction by DNA-bound NFKB or AP1 (tethering model) (Jonat et al. 1990; Cato and Wade 1996; McEwan et al. 1997; Karin 1998; De Bosscher et al. 2003).”
BackgroundGene-specific control of the TLR-induced inflammatory response
Foster, S. L., & Medzhitov, R. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.08.015 · Cited by 208
“Given at supraphysiological levels, GC powerfully suppress immune responses and often make patients susceptible to infection[50].”
BackgroundInfluentialBanu, N., Panikar, S. S., Leal, L. R., & Leal, A. R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117905 · Cited by 206
Thyroid hormone receptors, cell growth and differentiation
Pascual, A., & Aranda, A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.012 · Cited by 210
Fan, W., Huang, Y., Zheng, H., Li, S., Li, Z., Yuan, L., Cheng, X., He, C., & Sun, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110915 · Cited by 198
Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2
Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0012oc · Cited by 206
TANG, Z., JIANG, L., PENG, J., REN, Z., WEI, D., WU, C., PAN, L., JIANG, Z., & LIU, L. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1072 · Cited by 208
Mechanisms of Fever Production and Lysis: Lessons from Experimental LPS Fever
Roth, J., & Blatteis, C. M. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130033 · Cited by 177
New dimension of glucocorticoids in cancer treatment
Lin, K.-T., & Wang, L.-H. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.019 · Cited by 204
“…activating protein-1 (AP-1), nuclear factor (NF)- j B, cAMP response element-binding protein (CREB), interferon regulatory factor 3 (IRF3), nuclear factor of activated T cells (NFAT), signal transducer and activator of transcription (STAT), T-box expressed in T cells (T-Bet), and GATA-3 [20,21].”
Modulating Th2 Cell Immunity for the Treatment of Asthma
León, B., & Ballesteros-Tato, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637948 · Cited by 193
Intestinal Epithelial Cells Synthesize Glucocorticoids and Regulate T Cell Activation
Cima, I., Corazza, N., Dick, B., Fuhrer, A., Herren, S., Jakob, S., Ayuni, E., Mueller, C., & Brunner, T. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031958 · Cited by 201
“1636 Glucocorticoid Synthesis by Intestinal Epithelial Cells potently inhibit the production of proinflammatory cytokines, such as TNF � , presumably through the inhibition of the transcription factors NF � B and AP-1 ( 7 ).”
BackgroundLiu, B., Xu, C., Wu, X., Liu, F., Du, Y., Sun, J., Tao, J., & Dong, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.053 · Cited by 200
Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation
De Bosscher, K., Desmet, S. J., Clarisse, D., Estébanez-Perpiña, E., & Brunsveld, L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0349-5 · Cited by 199
Löwenberg, M., Stahn, C., Hommes, D. W., & Buttgereit, F. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.002 · Cited by 201
Molecular links between endocrine, nervous and immune system during chronic stress
Zefferino, R., Di Gioia, S., & Conese, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1960 · Cited by 204
“Indeed, GCs are potent anti-inflammatory agents and act by inducing apoptosis in monocytes, macrophages, and T cells (Amsterdam et al., 2002) and suppressing the NF-κB pathway (De Bosscher et al., 2003).”
BackgroundRusscher, H., Smit, P., van den Akker, E. L. T., van Rossum, E. F. C., Brinkmann, A. O., de Jong, F. H., Lamberts, S. W. J., & Koper, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0646 · Cited by 199
van Zuiden, M., Geuze, E., Willemen, H. L. D. M., Vermetten, E., Maas, M., Amarouchi, K., Kavelaars, A., & Heijnen, C. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.026 · Cited by 201
Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
Yuk, J.-M., Shin, D.-M., Lee, H.-M., Kim, J.-J., Kim, S.-W., Jin, H. S., Yang, C.-S., Park, K. A., Chanda, D., Kim, D.-K., et al. (2011) · Nature Immunology · doi:10.1038/ni.2064 · Cited by 188
Tissue-specific glucocorticoid action: a family affair
Gross, K. L., & Cidlowski, J. A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.009 · Cited by 180
“accepted that the anti-inflammatory properties of glucocorticoids involve trans repression and are caused by interference with AP-1- and NFκB-mediated gene transcription [2,34].”
BackgroundCorticosteroid receptor polymorphisms: Determinants of vulnerability and resilience
DeRijk, R. H., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.072 · Cited by 184
Yu, C.-Y., Mayba, O., Lee, J. V., Tran, J., Harris, C., Speed, T. P., & Wang, J.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015188 · Cited by 180
“Consensus motif analyses suggest that predicated GRE sequences are located in or nearby most glucocorticoid-activated genes. Interestingly, the predicated GRE motif is also highly represented in GBRs of glucocorticoid-repressed genes. Whether these predicated GRE motifs mediate the repressive effect of GR will be an i…”
BackgroundThe steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism
Zhou, C., Verma, S., & Blumberg, B. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07001 · Cited by 178
“Although transrepression by nuclear receptors and crosstalk between nuclear receptors and other signaling pathways have been extensively studied, the molecular mechanisms are still far from being completely understood [De Bosscher et al., 2003].”
BackgroundBelcher, J. D., Mahaseth, H., Welch, T. E., Vilback, A. E., Sonbol, K. M., Kalambur, V. S., Bowlin, P. R., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2004 · Cited by 180
“Glucocorticosteroids also induce expression of I B , which maintains NF- B in an inactive cytoplasmic complex (16).”
InfluentialWu, W., Pew, T., Zou, M., Pang, D., & Conzen, S. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411200200 · Cited by 177
Smoak, K., & Cidlowski, J. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00679-06 · Cited by 175
“While GR repression of the proinflammatory transcription factors NF-B and AP-1 is widely known as an important mechanism by which glucocorticoids exert their anti-inflammatory effects ( 13 ), glucocorticoids can also posttranscriptionally regulate genes of the inflammatory response.”
BackgroundType I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
Psarras, A., Emery, P., & Vital, E. M. (2017) · Rheumatology · doi:10.1093/rheumatology/kew431 · Cited by 168
Inflammation in Parkinson’s disease: role of glucocorticoids
Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175
“…pathways such as glucose-6-phosphotase, fatty acid synthase or tyrosine aminotransferase as well as anti-inflammatory genes e.g., (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (IκB-α), MAPK phosphatase (MPK-1), IL-4, IL-10 or annexin-1 (De Bosscher et al., 2003).”
BackgroundNew insights into the cell- and tissue-specificity of glucocorticoid actions
Quatrini, L., & Ugolini, S. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00526-2 · Cited by 164
Dehydroepiandrosterone: A neuroactive steroid
Stárka, L., Dušková, M., & Hill, M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.03.008 · Cited by 167
“ere we can see the intersection of signal pathways mediated y neuromediators and glucocorticoids, which both stimulate the xpression of AP-1 [69,70] and thus act in synergy with NMDA.”
BackgroundDual-specificity phosphatase 1: a critical regulator of innate immune responses
Abraham, S. M., & Clark, A. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341018 · Cited by 169
Microglia: Neuroimmune-sensors of stress
Frank, M. G., Fonken, L. K., Watkins, L. R., & Maier, S. F. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.01.001 · Cited by 156
Kleiman, A., & Tuckermann, J. P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.009 · Cited by 165
“This protein-protein interaction is designated as “tethering mechanism” (Beato et al., 1995; De Bosscher et al., 2003).”
BackgroundRibosome-inactivating proteins: current status and biomedical applications
Puri, M., Kaur, I., Perugini, M. A., & Gupta, R. C. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.007 · Cited by 159
Oxidative modifications of S100 proteins: functional regulation by redox
Lim, S. Y., Raftery, M. J., Goyette, J., Hsu, K., & Geczy, C. L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008608 · Cited by 157
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 189
Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger
Frank, M. G., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.004 · Cited by 160
“…of evidence indicates that (1) GCs ameliorate stress-induced defense mechanisms (e.g. pro-inflammatory cytokines) (Munck and Naray-Fejes-Toth, 1994) and (2) GCs directly suppress innate inflammatory immune mediators such as the pro-inflammatory transcription factor NF-jB (De Bosscher et al., 2003).”
BackgroundGlucocorticoid-Induced Osteoporosis
Frenkel, B., White, W., & Tuckermann, J. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2895-8_8 · Cited by 146
“Indirect interactions involve, for example, regulation of phosphorylation and competition for common co-activators [ 164 ].”
BackgroundHodgson, P. D., Aich, P., Manuja, A., Hokamp, K., Roche, F. M., Brinkman, F. S. L., Potter, A., Babiuk, L. A., & Griebel, P. J. (2005) · Comparative and Functional Genomics · doi:10.1002/cfg.474 · Cited by 153
Glucocorticoid receptors: finding the middle ground
Desmet, S. J., & De Bosscher, K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88886 · Cited by 147
“For example, transrepression can involve a sequestration or squelching mechanism whereby the GR-targeted, DNA-bound TF detaches from the DNA, or a tethering mechanism whereby the GR remains associated with the DNA-bound TF (12).”
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.